麳麞奇antigen CA19-9 Radioimmunoassay Panel - Taiwan Registration 256fb76d9fc9775af53c4fafdb841080
Access comprehensive regulatory information for 麳麞奇antigen CA19-9 Radioimmunoassay Panel in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 256fb76d9fc9775af53c4fafdb841080 and manufactured by Shin Jin Medics Inc.. The authorized representative in Taiwan is MEGA BONA INTERNATIONAL CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
256fb76d9fc9775af53c4fafdb841080
DHAS5603705207
Product Details
This product is a quantitative measure of glycocate antigen CA19-9 in human serum using in vitro radioimmunoassay.
C Immunology and microbiology
C.6010 腫瘤相關抗原免疫試驗系統
Input;; Consent must be attached to the import (with the consent of the Atomic Energy Commission must be obtained for each import); QMS/QSD
Dates and Status
Jan 12, 2024
Jan 12, 2029